Even though patients with HAE-C1INH may not have an increased risk of thrombosis (37), recent preclinical and clinical studies indicate that high plasma levels of C1 INH reduce the risk of venous thromboembolism (38). This evidence concerns the gene SERPING1 and venous thromboembolism.